HTRS2025.O8C.5 Phase I Study of VGA039 in Individuals with Von Willebrand Disease Demonstrates Sustained Drug Concentrations, Increased Thrombin Generation, and Decreased Bleeding After Single Subcutaneous Injection

Benzer Materyaller

• The clinical usefulness of measuring thrombin generation
  Yazar:: Coenraad H. Hemker
  Baskı/Yayın Bilgisi: (2023-03-01)
• Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab
  Yazar:: Yesim Dargaud, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-04-01)
• Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation
  Yazar:: Saartje Bloemen, ve diğerleri
  Baskı/Yayın Bilgisi: (2013-04-01)
• Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19
  Yazar:: Matthias H. Busch, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-12-01)
• Differential diagnosis of neonatal alloimmune thrombocytopenia: Type 2B von Willebrand disease
  Yazar:: Mathilde Penel-Page, ve diğerleri
  Baskı/Yayın Bilgisi: (2017-11-01)